Loading company…
Macomics Ltd is an Edinburgh biopharmaceutical company developing therapies that target macrophage activity.
Founded in 2018 and headquartered in Edinburgh, UK, Macomics Ltd uses its proprietary ENIGMAC platform to create genetic models and find new targets that modulate macrophage functions. Its work covers tumor subtypes, neurological disorders and fibrotic and inflammatory diseases. In July 2021 the company raised GBP 4.24 million in a Seed round led by Epidarex Capital, with Caribou Property Limited and Scottish Enterprise participating. CEO Steve M leads the company.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in